Beaumont, TX 的 阿茲海默症 臨床試驗
6 項針對 阿茲海默症 的研究正在 Beaumont（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
招募中2 期
- Gadolin Research, Beaumont
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
招募中3 期
- Gadolin Research, LLC, Beaumont
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
招募中2 期
- Gadolin Research ( Site 1032), Beaumont
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
招募中3 期
- Gadolin Research, Beaumont
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
招募中3 期
- Gadolin Research, Beaumont
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
招募中觀察性研究歡迎健康志工
- Gadolin Research LLC, Beaumont
其他城市的 阿茲海默症 試驗
- Boston, MA26 項研究
- Orlando, FL25 項研究
- St. Louis, MO22 項研究
- New York City, NY21 項研究
- Miami, FL20 項研究
- Tampa, FL17 項研究
- Atlanta, GA16 項研究
- The Villages, FL15 項研究
- Philadelphia, PA15 項研究
- Phoenix, AZ15 項研究
- Indianapolis, IN14 項研究
- Los Angeles, CA14 項研究
Beaumont 的其他研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。